Clinical Trial Update: Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab in combination with chemotherapy as neoadjuvant/adjuvant therapy for non-small cell lung cancer; the study inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Peking University | Conditions: Stage IIIB(N2) Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING